Status:
COMPLETED
Osteofibrous Dysplasia (Kempson-Campanacci's Disease)
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Osteofibrous Dysplasia
Eligibility:
All Genders
Brief Summary
The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potenti...
Eligibility Criteria
Inclusion
- Male and female patients treated at Rizzoli Institute from 01 Jan 1943 to 31 Dic 2011
- Diagnosis of osteofibrous dysplasia pathologically confirmed
- Written informed consent prior to any study-specific analysis and/or data collection
Exclusion
- Patients with histological diagnosis different from osteofibrous dysplasia
Key Trial Info
Start Date :
August 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04104763
Start Date
August 8 2019
End Date
September 30 2021
Last Update
August 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy, 40136